造影剤の世界市場:ヨード造影剤、ガドリニウム造影剤、バリウム造影剤

◆英語タイトル:Global Contrast Media/Contrast Agents Market 2015-2019
◆商品コード:IRTNTR6045
◆発行会社(調査会社):Technavio
◆発行日:2015年6月3日
◆ページ数:84
◆レポート言語:英語
◆レポート形式:pdf
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:材料
◆販売価格オプション(消費税別)
Single UserUSD2,500 ⇒換算¥282,500見積依頼/購入/質問フォーム
Five UserUSD3,000 ⇒換算¥339,000見積依頼/購入/質問フォーム
Enterprise License(全社内共有可)USD4,000 ⇒換算¥452,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTechnavio社の日本における正規販売代理店です。Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、造影剤の世界市場について調査・分析し、エグゼクティブサマリー、市場概観、業界の構造分析、造影剤の世界市場規模及び予測、用途別分析、製品別分析、地域別分析、主要国別分析、購買基準、市場成長要因、市場の課題、市場動向、競争状況、主要企業(ベンダー)分析などの情報をお届けいたします。
【レポートの概要】

About contrast media/contrast agent
Contrast media/contrast agents are chemicals used in diagnostic imaging procedures such as CT scans, MRIs, X-rays, ultrasounds, and related procedures. They enhance the internal structure of the body and provide high-quality images, which help in providing an accurate diagnosis. It is widely used in radiology, interventional radiology, and interventional cardiology.
Technavio’s analysts forecast the global contrast media/contrast agent market to grow at a CAGR of 6.95 percent over the period 2014-2019.

[Covered in this report]
The global contrast media/contrast agent market can be segmented into three based on type: iodinated, gadolinium-based, and barium-based contrast media/contrast agent. Iodinated contrast media is the most widely preferred, as it can be easily administered orally.
Technavio’s report, Global Contrast Media/Contrast Agent Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers North America, Europe, APAC, and ROW; it also covers the global biomedical metal market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

[Key regions]
• APAC
• Europe
• North America
• ROW

[Key vendors]
• Bayer Healthcare
• Bracco Diagnostic
• Covidien
• GE Healthcare
• Guerbet Group

[Other prominent vendors]
• Acusphere
• Alseres Pharmaceuticals
• Aposense
• Avid Radiopharmaceuticals
• Bayer Schering Pharma
• BEILU Pharmaceutical
• Cell]Point
• China Resources Double-crane Pharmaceutical
• Draximage
• Eisai
• Eli Lilly
• Endocyte
• Eusa Pharma
• Hovione FarmaCiencia
• Imcor Pharmaceutical
• Immunomedics
• Insight Agents
• Jiangsu Hengrui Medicine
• King Pharmaceuticals
• Lantheus Medical Imaging
• Macrocyclics
• MDS Nordion
• Nanopet Pharma
• Nanoscan Imaging
• Pharmacyclics
• Point Biomedical
• Sanochemia Pharmazeutika
• Shanghai Xudong Haipu Pharmaceutical
• Spago Imaging
• Subhra Pharma Private
• Taejoon Pharm
• VisEn Medical
• Yangtze River Pharmaceutical

[Market driver]
• Increased demand for diagnostic imaging
• For a full, detailed list, view our report

[Market challenge]
• Clinical studies revealing adverse effects associated with contrast media
• For a full, detailed list, view our report

[Market trend]
• Growth in medical imaging technology
• For a full, detailed list, view our report

[Key questions answered in this report]
• What will the market size be in 2018 and what will the growth rate be?
• What are the key market trends?
• What is driving this market?
• What are the challenges to market growth?
• Who are the key vendors in this market space?
• What are the market opportunities and threats faced by the key vendors?
• What are the strengths and weaknesses of the key vendors?

【レポートの目次】

01. Executive Summary

02.List of Abbreviations

03.Scope of the Report
03.1 Market Overview
03.2 Product Offerings

04.Market Research Methodology
04.1 Market Research Process
04.2 Research Methodology

05.Introduction

06.Global Contrast Media/Contrast Agents Market
06.1 Market Size and Forecast
06.2 Five Forces Analysis

07.Market Segmentation by Product Type
07.1 Segmentation of Global Contrast Media/Contrast Agents Market by Product Type
07.2 Segmentation of Global Contrast Media/Contrast Agents Market by Product Type 2014
07.3 Global Iodinated Contrast Media Market
07.3.1 Market Outlook
07.4 Global Gadolinium-based Contrast Media Market
07.4.1 Market Outlook
07.5 Global Barium-based Contrast Media Market
07.5.1 Market Outlook

08.Market Segmentation by Medical Procedure
08.1 Segmentation of Global Contrast Media/Contrast Agents Market by Medical Procedure 2014
08.1.1 Global X-ray, Ultrasound, and Fluoroscopy Market
08.1.2 Global CT Scan Market
08.1.3 Global MRI Scan Market
08.1.4 Global Nuclear Medicine Market

09.Market Segmentation by Application
09.1 Segmentation of Global Contrast Media/Contrast Agents Market by Application 2014

10.Geographical Segmentation
10.1 Segmentation of Global Contrast Media/Contrast Agents Market by Geography 2014-2019
10.2 Contrast Media/Contrast Agents Market in North America
10.2.1 Market Size and Forecast
10.3 Contrast Media/Contrast Agents Market in Europe
10.3.1 Market Size and Forecast
10.4 Contrast Media/Contrast Agents Market in APAC
10.4.1 Market Size and Forecast
10.5 Contrast Media/Contrast Agents Market in ROW
10.5.1 Market Size and Forecast

11.Key Leading Countries
11.1 US
11.2 China
11.3 India

12.Buying Criteria

13.Market Growth Drivers

14.Drivers and their Impact

15.Market Challenges

16.Impact of Drivers and Challenges

17.Market Trends

18.Trends and their Impact

19.Vendor Landscape
19.1 Competitive Scenario
19.2 Major Vendors Analysis 2014
19.3 Other Prominent Vendors

20.Key Vendor Analysis
20.1 Bayer HealthCare
20.1.1 Key Facts
20.1.2 Business Overview
20.1.3 Business Segmentation by Revenue 2013
20.1.4 Business Segmentation by Revenue 2012 and 2013
20.1.5 Geographical Segmentation by Revenue 2013
20.1.6 Business Strategy
20.1.7 Recent Developments
20.1.8 SWOT Analysis
20.2 Bracco Diagnostics
20.2.1 Key Facts
20.2.2 Business Overview
20.2.3 Products Categories
20.2.4 Recent Developments
20.2.5 SWOT Analysis
20.3 Covidien plc
20.3.1 Key Facts
20.3.2 Business Overview
20.3.3 Business Segmentation
20.3.4 Business Segmentation by Revenue 2012 and 2013
20.3.5 Geographical Segmentation by Revenue 2013
20.3.6 Business Strategy
20.3.7 Key Information
20.3.8 SWOT Analysis
20.4 GE Healthcare
20.4.1 Key Facts
20.4.2 Business Overview
20.4.3 Business Segmentation
20.4.4 Business Strategy
20.4.5 Key Developments
20.4.6 SWOT Analysis
20.5 Guerbet
20.5.1 Key Facts
20.5.2 Business Overview
20.5.3 Product Segmentation by Revenue 2014
20.5.4 Business Segmentation by Revenue 2013 and 2014
20.5.5 Recent Developments
20.5.6 SWOT Analysis

21.Other Reports in this Series

[List of Exhibits]

Exhibit 1: Market Research Methodology
Exhibit 2: Global Contrast Media/Contrast Agents Market 2014-2019 ($ billions)
Exhibit 3: Segmentation of Global Contrast Media/Contrast Agents Market by Product Type
Exhibit 4: Segmentation of Global Contrast Media/Contrast Agents Market by Product Type 2014
Exhibit 5: Commonly Used Iodinated Contrast Agents
Exhibit 6: Commonly Used Gadolinium-based Contrast Agents
Exhibit 7: Global Contrast Media/Contrast Agents Market by Medical Procedure 2014
Exhibit 8: Segmentation of Global X-ray Market by Type 2014
Exhibit 9: Comparison of Analog and Digital X-ray Systems
Exhibit 10: Segmentation of Global Digital X-ray Market by Geography 2014
Exhibit 11: Segmentation of Global MRI Scan Market by Geography 2014
Exhibit 12: Segmentation of Global Nuclear Imaging Market by Geography 2014
Exhibit 13: Global Contrast Media/Contrast Agents Market by Application 2014
Exhibit 14: Segmentation of Global Contrast Media/Contrast Agents Market by Geography 2014 and 2019
Exhibit 15: Contrast Media/Contrast Agents Market in North America 2014-2019 ($ billions)
Exhibit 16: Contrast Media/Contrast Agents Market in Europe 2014-2019 ($ billions)
Exhibit 17: Contrast Media/Contrast Agents Market in APAC 2014-2019 ($ billions)
Exhibit 18: Contrast Media/Contrast Agents Market in ROW 2014-2019 ($ billions)
Exhibit 19: New Cancer Cases, Deaths, and 5-Year Relative Survival (number per 1,000,000 persons)
Exhibit 20: Major Countries Per Capita Healthcare Costs ($)
Exhibit 21: GDP Forecast of Major EU Countries 2013-2020 ($ billions)
Exhibit 22: Population Forecast in BRIC Nations 2013-2020 (in millions)
Exhibit 23: Global Contrast Media/Contrast Agents Market: Major Vendors in 2014
Exhibit 24: Bayer HealthCare: Business Segmentation by Revenue 2013
Exhibit 25: Bayer HealthCare: Business Segmentation by Revenue 2012 and 2013 (US$ billion)
Exhibit 26: Bayer HealthCare: Geographical Segmentation by Revenue 2013
Exhibit 27: Bracco Diagnostics: Products Categories
Exhibit 28: Covidien: Business Segmentation 2013
Exhibit 29: Covidien: Business Segmentation by Revenue 2012 and 2013 (US$ million)
Exhibit 30: Covidien: Geographical Segmentation by Revenue 2013
Exhibit 31: GE Healthcare: Business Segmentation 2013
Exhibit 32: Guerbet: Product Segmentation by Revenue 2014
Exhibit 33: Guerbet: Business Segmentation by Revenue 2013 and 2014 ($ million)



【掲載企業】

Bayer Healthcare, Bracco Diagnostic, Covidien, GE Healthcare and Guerbet Group, Acusphere, Alseres Pharmaceuticals, Aposense, Avid Radiopharmaceuticals, Bayer Schering Pharma, BEILU Pharmaceutical, Cell Point, China Resources Double-crane Pharmaceutical, Draximage, Eisai, Eli Lilly, Endocyte, Eusa Pharma, Hovione FarmaCiencia, Imcor Pharmaceutical, Immunomedics, Insight Agents, Jiangsu Hengrui Medicine, King Pharmaceuticals, Lantheus Medical Imaging, Macrocyclics, MDS Nordion, Nanopet Pharma, Nanoscan Imaging, Pharmacyclics, Point Biomedical, Sanochemia Pharmazeutika, Shanghai Xudong Haipu Pharmaceutical, Spago Imaging, Subhra Pharma Private, Taejoon Pharm, VisEn Medical, Yangtze River Pharmaceutical

【レポートのキーワード】

造影剤(コントラスト剤)、ヨード造影剤、ガドリニウム造影剤、バリウム造影剤、CT撮影、MRIスキャン、核医学、医療機器、画像診断

【調査方法】

一次資料による調査(業界専門家、ベンダー、代理店、顧客等を対象にしたデプスインタビュー調査など)及び二次資料による調査(Technavio独自のプラットフォーム、産業書籍、企業報告書、ニュース記事、アナリストレポート、貿易協会、政府機関発行データなど)

★調査レポート[造影剤の世界市場:ヨード造影剤、ガドリニウム造影剤、バリウム造影剤] (コード:IRTNTR6045)販売に関する免責事項を必ずご確認ください。
★調査レポート[造影剤の世界市場:ヨード造影剤、ガドリニウム造影剤、バリウム造影剤]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆